RT Book, Section
A1 Murri, PharmD, MBA, Nelda
A2 Brunton, Laurence L.
A2 Hilal-Dandan, Randa
A2 Knollmann, Björn C.
SR Print(0)
ID 1164576137
T1 Goodman & Gilman Year in Review New and Noteworthy FDA Approvals
T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9781259584732
LK accesspharmacy.mhmedical.com/content.aspx?aid=1164576137
RD 2024/04/24
AB In  2017  the  U.S.  Food  and  Drug  Administration  (FDA)  approved  40  noteworthy  new  drug  products  and  granted  48  noteworthy  new  biologic  licenses.  Among  the  40  new  drug  products  are: